EverydayHealthLogo
DB

Dr. Daniel Bernstein, MD

Palo Alto, CA

41 Years of Experience

Accepting patients

    Who is Dr. Bernstein, Pediatric Cardiologist in Palo Alto, CA?

    Dr. Daniel Bernstein, MD is a Pediatric Cardiologist, who primarily practices in Palo Alto, CA. He has been practicing for over 41 years and is board certified. Dr. Bernstein graduated from New York University School of Medicine and completed his residency at Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics. Dr. Bernstein is fluent in English, Chinese, Korean, Spanish, Tagalog, and Vietnamese, and is currently seeing new patients. Dr. Bernstein’s practice accepts Kaiser Permanente, Medicare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Bernstein’s office at (650) 497-8000.
    CastleConnolyTopDoctors

    Castle Connolly Top Doctor

    Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.

    What are Areas of Expertise for Dr. Bernstein?

    Dr. Daniel Bernstein, MD is a highly-rated, board-certified Pediatric Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Bernstein empowers patients to confidently navigate their health journey, specializing in Heart Failure, Transplant Medicine-Heart, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Bernstein is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Bernstein go to medical school and complete their residency?

    • Residency: Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics | Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore) Program

    • Medical School: New York Univ Sch of Med, New York Ny | New York University School of Medicine

    Is Dr. Bernstein board certified as a Pediatric Cardiologist?

    Yes, Dr. Daniel Bernstein, MD is board certified by the American Board of Pediatrics

    What languages does Dr. Bernstein speak?

    Dr. Bernstein and their clinical team can communicate with patients in the following languages:

    • Chinese
    • English
    • Korean
    • Spanish
    • Tagalog
    • Vietnamese

    What conditions does a Pediatric Cardiologist like Dr. Bernstein typically treat?

    As a Pediatric Cardiologist, Dr. Bernstein diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Bernstein. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.

    Also known as:

    • Tetralogy of Fallot
    • Discordant Ventriculoarterial Connection
    • Congenital Heart Defects
    • Critical congenital heart disease
    • TOF
    • Blue Baby Syndrome
    • Complex Heart Defect
    • Transposition of the Great Arteries
    • Congenital Heart Anomaly
    • Heart Artery Misconnection

    ICD-10 Codes:

    • Q213: Tetralogy of Fallot
    • Q203: Discordant ventriculoarterial connection

    Also known as:

    • Having a Heart Transplant
    • Heart Transplantation
    • Cardiac transplant
    • Heart replacement surgery
    • Post-heart transplant

    ICD-10 Codes:

    • Z941: Heart transplant status

    What procedures does a Pediatric Cardiologist like Dr. Bernstein typically perform?

    As a Pediatric Cardiologist, procedures performed by Dr. Daniel Bernstein may include:

    Please contact Dr. Bernstein's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Bernstein accept my insurance?

    Dr. Bernstein accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Bernstein accept in Palo Alto, CA?

    Dr. Bernstein in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Blue Shield of California

    • California Water Service Group

    • City of Los Angeles

    • Community Health Network of Washington

    • CVS Health (formerly Aetna)

    • Kaiser Permanente

    • Molina Healthcare

    • Santa Cruz County

    • State of California

    • UnitedHealth Group

    View All Insurances

    Where is Dr. Bernstein's office located?

    Dr. Daniel Bernstein's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (650) 497-8000

    Get Directions

    What hospitals are Dr. Bernstein affiliated with?

    Dr. Bernstein has admitting privileges at the following hospitals:

    Stanford Medicine Children’s Health,Palo Alto, CA

    Recognitions

    Publications

    • Multi-institutiol Study of Outcomes After Pediatric Heart Transplantation, 2014

    • Orthotopic heart transplantation in two infants with histiocytoid cardiomyopathy, 2013

    • Deletion of the beta 2-adrenergic receptor prevents the development of cardiomyopathy in mice, 2013

    • Lower socioeconomic status is associated with worse outcomes after both listing, 2013

    • Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy, 2013

    • Physiologic and molecular characterization of a murine model of right ventricular volume overload., 2013

    • Abdomil complaints as a common first presentation of heart failure, 2013

    • Intermediate-term outcomes after combined heart, 2013

    • Sacrificial layer technique for axial force post assay of immature cardiomyocytes, 2013

    • Brg1 governs distinct pathways to direct multiple, 2013

    • Loss of adenomatous poliposis coli, 2012

    • Loss of Adenomatous Poliposis Coli, 2012

    • Rel function and genetic polymorphisms in pediatric heart transplant recipients, 2012

    • Outcomes of Children Following a First Hospitalization for Dilated Cardiomyopathy, 2012

    • Dymic microR expression during the transition from right ventricular hypertrophy to failure, 2012

    • Use of the Impella 5.0 as a bridge from ECMO to implantation of the HeartMate II left ventricular, 2012

    • In Vivo Functiol and Transcriptiol Profiling of Bone Marrow Stem Cells After Transplantation Into, 2012

    • Pharmacological inhibition of beta IIPKC is cardioprotective in late-stage hypertrophy, 2011

    • beta 2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell, 2011

    • Cardiac pressure overload hypertrophy is differentially regulated by beta, 2011

    • Familial Cardiac Valvulopathy Due to Filamin A Mutation, 2011

    • Gene Polymorphisms Impact the Risk of Rejection With Hemodymic Compromise: A Multicenter Study, 2011

    • Calibrated micropost arrays for biomechanical characterisation of cardiomyocytes, 2011

    • Clinical usefulness of a novel C1q, 2011

    • NEW DIRECTIONS IN BASIC RESEARCH IN HYPERTROPHY AND HEART FAILURE, 2011

    • THE ROLE OF ?-ADRENERGIC RECEPTORS IN HEART FAILURE, 2011

    • Association of genetic polymorphisms, 2010

    • Interagency Registry for Mechanically Assisted Circulatory Support, 2010

    • Behcet's disease and heart transplantation: A word of caution, 2010

    • Endogenous regulation of cardiovascular function by apelin-APJ, 2009

    • Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting, 2009

    • Hypercholesterolemia impairs exercise capacity in mice, 2009

    • Genotypic Variation and Phenotypic Characterization of Granzyme B Gene Polymorphisms, 2009

    • Molecular and physiological characterization of RV remodeling in a murine model of pulmory stenosis, 2008

    • Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation, 2008

    • Prevention of pediatric graft corory artery disease: Atorvastatin, 2008

    • Microsystems for biomechanical measurements, 2008

    • Gene expression profiling distinguishes a molecular sigture, 2007

    • Indications for heart transplantation in pediatric heart disease, 2007

    • Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic, 2006

    • Pediatric cardiac transplantation., 2006

    • Outcome of listing for cardiac transplantation for failed Fontan - A multi-institutiol study, 2006

    • Neurologic events in neotes treated surgically for congenital heart disease, 2006

    • Differential cardiotoxic/cardioprotective effects, 2006

    • Ten- and 20-year survivors of pediatric orthotopic heart transplantation, 2006

    • Effect of targeted deletions of beta(1)-, 2006

    • Differential cardioprotective/cardiotoxic effects mediated by ss-adrenergic receptor subtypes, 2005

    • Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension, 2005

    • Induction therapy for pediatric and adult heart transplantation, 2005

    • Experience of percutaneous corory intervention, 2005

    • The role of beta-adrenergic receptor sigling in cardioprotection., 2005

    • The role of beta-adrenergic receptor sigling in cardioprotection, 2005

    • Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients, 2005

    • The endogenous peptide apelin potently improves cardiac contractility, 2005

    • Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic, 2004

    • Intertiol society for heart and lung transplantation, 2004

    • The mouse as a model of cardiovascular adaptations to microgravity, 2004

    • Microarray alysis of gene expression after transverse aortic constriction in mice, 2004

    • Linearity versus cross-talk, 2004

    • Identifying cardiac transplant rejection in children, 2004

    • Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience, 2004

    • Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation, 2003

    • Exercise assessment of transgenic models of human cardiovascular disease, 2003

    • Efficacy and safety of atorvastatin after pediatric heart transplantation, 2002

    • Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice, 2002

    • Cardiovascular and metabolic alterations in mice lacking beta 1- and beta 2-adrenergic receptors, 2002

    • Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients, 2002

    • Infant heart transplantation at Stanford: Growth and neurodevelopmental outcome, 2002

    • Survey of current practices in use of amiodarone, 2001

    • L-Arginine enhances aerobic exercise capacity in association with augmented nitric oxide production, 2001

    • Efficacy and safety of atorvastatin after pediatric cardiac transplantation., 2001

    • Outcome while awaiting heart transplantation in children, 2000

    • Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients., 2000

    • Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart, 2000

    • The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation., 1999

    • Heart transplantation in children, 1999

    • QT dispersion predicts ventricular arrhythmia, 1999

    • Abnormal regulation of the sympathetic nervous system in alpha, 1999

    • Targeted disruption of the beta 2 adrenergic receptor gene, 1999

    • Cardiovascular and metabolic alterations in mice lacking both beta 1-and beta 2, 1999

    • American Pediatric Society Society for Pediatric Research code of responsible conduct of research, 1999

    • Phospholamban deficiency does not compromise exercise capacity, 1999

    • Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training, 1999

    • Limb blood flow during exercise is dependent on nitric oxide, 1998

    • Alterations in dymic heart rate control in the beta(1)-adrenergic receptor knockout mouse, 1998

    • Elective transplant pneumonectomy, 1998

    • The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2, 1998

    • Survival and risk factors for death after cardiac transplantation in infants - A multi, 1997

    • Predicting outcome after listing for heart transplantation in children, 1997

    • Cardiovascular indexes in the mouse at rest and with exercise, 1997

    • Developmental and afterload stress regulation of heat shock proteins in the ovine myocardium, 1997

    • Cardiovascular regulation in mice lacking alpha(2)-adrenergic receptor subtypes b and c, 1996

    • Targeted disruption of the mouse beta 1-adrenergic receptor gene, 1996

    • CARDIAC TRANSPLANTATION FOR HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH SENGERS-SYNDROME, 1995

    • COLCHICINE AND CYTOCHALASIN-B ENHANCE CYCLIC-AMP ACCUMULATION VIA POSTRECEPTOR ACTIONS, 1995

    • ARTERIAL SWITCH AND RESECTION OF HEPATIC HEMANGIOENDOTHELIOMA, 1995

    • Pediatric cardiac transplantation. The Stanford experience., 1994

    • SUCCESSFUL THROMBOLYSIS OF A THROMBOSED ST-JUDE MEDICAL MITRAL PROSTHESIS IN A 2-MONTH-OLD INFANT, 1994

    • NEOPLASTIC DISORDERS AFTER PEDIATRIC HEART-TRANSPLANTATION, 1993

    • Neoplastic disorders after pediatric heart transplantation., 1993

    • HEART-TRANSPLANTATION IN INFANCY, 1993

    • PRIMARY STRUCTURE OF THE MOUSE BETA(1)-ADRENERGIC RECEPTOR GENE, 1993

    • Update on cardiac transplantation in infants and children., 1993

    • ALTERATION IN GS-MEDIATED SIGL TRANSDUCTION IN S49 LYMPHOMA, 1993

    • TRANSCRIPTIOL REGULATION OF LEFT-VENTRICULAR BETA-ADRENERGIC RECEPTORS DURING CHRONIC HYPOXIA, 1992

    • CURRENT APPROACH TO HYPOPLASTIC LEFT HEART SYNDROME - PALLIATION, TRANSPLANTATION, OR BOTH, 1992

    • CARDIAC GROWTH AFTER PEDIATRIC HEART-TRANSPLANTATION, 1992

    • DECREASED SERUM INSULIN-LIKE GROWTH FACTOR, 1992

    • ALTERATIONS IN POSTTAL INTESTIL FUNCTION DURING CHRONIC HYPOXEMIA, 1992

    • HEART, HEART-LUNG, AND LUNG TRANSPLANTATION IN THE 1ST YEAR OF LIFE, 1992

    • REGULATION OF ATRIAL AUTONOMIC RECEPTORS IN EXPERIMENTAL CYANOTIC HEART-DISEASE, 1991

    • PEDIATRIC HEART-TRANSPLANTATION AT STANFORD - RESULTS OF A 15-YEAR EXPERIENCE, 1991

    • EBSTEINS-ANOMALY APPEARING IN THE NEOTE - A NEW SURGICAL APPROACH, 1991

    • COMPARATIVE CIRCULATORY EFFECTS OF ISOPROTERENOL AND DOPAMINE IN LAMBS WITH EXPERIMENTAL CYANOTIC, 1991

    • Pediatric heart transplantation., 1990

    • DIFFERENTIAL REGULATION OF RIGHT AND LEFT-VENTRICULAR BETA, 1990

    • HEART-TRANSPLANTATION IN CHILDREN, 1989

    What is Dr. Bernstein's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Bernstein's National Provider Identifier (NPI) number is 1972527687.

    What common questions do patients ask about Dr. Bernstein?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Bernstein

    What is Dr. Daniel Bernstein's specialty?

    What does a Pediatric Cardiologist do?

    A pediatric cardiologist provides comprehensive care for children with cardiovascular issues, offering expertise in diagnosing, treating, and managing heart and blood vessel conditions. This specialist is skilled in selecting, performing, and interpreting structural and functional assessments of the heart and blood vessels, as well as conducting thorough clinical evaluations of cardiovascular diseases in young patients.

    Is Dr. Daniel Bernstein affiliated with a ranked Castle Connolly Top Hospital?

    No, Dr. Bernstein is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Pediatric Cardiologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Pediatric Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Dr. Daniel Bernstein accepting new patients in Palo Alto, CA?

    Yes, Dr. Daniel Bernstein is accepting new patients at this time.

    Does Dr. Daniel Bernstein offer online booking?

    Please contact Dr. Bernstein's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Dr. Daniel Bernstein?

    Please contact Dr. Bernstein's office at (650) 497-8000 to schedule an appointment.

    Where is Dr. Bernstein's office located?

    Dr. Bernstein's office is located in Palo Alto, CA.

    Which board certifications does Dr. Daniel Bernstein have?

    Dr. Daniel Bernstein is certified by the American Board of Pediatrics.